Cerus (CERS) Cash from Investing Activities (2010 - 2026)

Cerus (CERS) reported Cash from Investing Activities of $9.9 million for Q1 2026, up 929.27% on a YoY basis from $957962.1 in Q1 2025, and up 815.53% sequentially from -$1.4 million in Q4 2025.

Cerus (CERS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Cerus (CERS) has 17 years of Cash from Investing Activities data on file, last reported at $9.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 929.27% year-over-year to $9.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 145.37% YoY), and the FY2025 full-year result was -$6.2 million, up 24.17% from the prior year.
  • Cash from Investing Activities advanced to $9.9 million in Q1 2026, from -$1.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.9 million in Q1 2026 to a low of -$7.3 million in Q4 2024.
  • A 5-year average of $744294.1 and a median of -$1.1 million in 2025 frame the typical range for Cash from Investing Activities.
  • Peak annual rise in Cash from Investing Activities reached 1851.64% in 2024, while the deepest fall reached 405.15% in 2024.
  • Tracing CERS's Cash from Investing Activities over 5 years: stood at $7.4 million in 2022, then advanced by 11.28% to $8.2 million in 2023, then slumped by 188.68% to -$7.3 million in 2024, then surged by 81.09% to -$1.4 million in 2025, then soared by 815.53% to $9.9 million in 2026.
  • Business Quant data shows CERS's Cash from Investing Activities at $9.9 million in Q1 2026, -$1.4 million in Q4 2025, and -$2.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Cerus 600.87 Mn 520.44 Mn 27.89 Mn 9.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.86 Mn
Mar 31, 2026 9.86 Mn
Dec 31, 2025 -1.38 Mn
Dec 31, 2025 -1.38 Mn
Sep 30, 2025 -2.51 Mn
Sep 30, 2025 -2.51 Mn
Jun 30, 2025 -1.09 Mn
Jun 30, 2025 -1.09 Mn
Mar 31, 2025 -1.19 Mn
Mar 31, 2025 -1.19 Mn
Dec 31, 2024 -7.29 Mn
Dec 31, 2024 -7.29 Mn
Sep 30, 2024 4.82 Mn
Sep 30, 2024 4.82 Mn
Jun 30, 2024 -7.11 Mn
Jun 30, 2024 -7.11 Mn
Mar 31, 2024 1.45 Mn
Mar 31, 2024 1.45 Mn
Dec 31, 2023 8.22 Mn
Dec 31, 2023 8.22 Mn